T. Olczyk

发表

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study

B. Jarzab, D. Handkiewicz-Junak, A. Kukulska, 2009, Thyroid research.

[Indications for surgery of thyroid cancer based on bioptate molecular examination].

E. Chmielik, E. Gubała, D. Handkiewicz-Junak, 2006, Endokrynologia Polska.

Treatment with sorafenib in advanced thyroid cancer - a case report.

B. Jarzab, J. Krajewska, J. Roskosz, 2010, Endokrynologia Polska.

Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer

B. Jarzab, D. Handkiewicz-Junak, Agnieszka Kotecka-Blicharz, 2021, Annals of Nuclear Medicine.

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes

B. Jarzab, D. Handkiewicz-Junak, J. Krajewska, 2020, Archives of medical science : AMS.

Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer

B. Jarzab, J. Krajewska, T. Olczyk, 2016, Expert review of clinical pharmacology.

Role of nuclear medicine imaging in differential diagnosis of accessory spleens in patients after splenectomy

B. Bobek-Billewicz, B. Jarzab, A. d’Amico, 2012, Polish journal of radiology.

Loss of heterozygosity in 73 human thyroid tumors.

M. Wiench, B. Jarzab, A. Wozniak, 2005, Neuro endocrinology letters.

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update.

Andrzej Cichocki, Agnieszka Kotecka-Blicharz, Marek Niedziela, 2018, Endokrynologia Polska.